Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tullio Sulser

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Plos One|July 15, 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLotta von Boehmer, Lukas Keller, Ashkan Mortezavi, et al.
International Journal of Cancer|February 21, 2009
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapySpasenija Savic, Inti Zlobec, George N Thalmann, et al.
BMC Cancer|July 2, 2010
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scoresKristian Ikenberg, Florian R Fritzsche, Ursina Zuerrer-Haerdi, et al.
Journal of Pathology Informatics|March 9, 2016
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancerNiels J Rupp, Peter J Schüffler, Qing Zhong, et al.
European Urology|December 13, 2005
Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working GroupJens Rassweiler, Jens Stolzenburg, Tullio Sulser, et al.
Neoplasia (New York, N.Y.)|July 19, 2012
Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinomaGunther Boysen, Damaris Bausch-Fluck, Claudio R Thoma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
The Prostate|February 18, 2021
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysisMarian S Wettstein, Luke A David, Clinsy Pazhepurackel, et al.
Urologic Oncology|August 2, 2015
Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial designWillemien van den Bos, Berrend G Muller, Daniel M de Bruin, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Plos One|July 15, 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancerLotta von Boehmer, Lukas Keller, Ashkan Mortezavi, et al.
International Journal of Cancer|February 21, 2009
The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapySpasenija Savic, Inti Zlobec, George N Thalmann, et al.
BMC Cancer|July 2, 2010
Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scoresKristian Ikenberg, Florian R Fritzsche, Ursina Zuerrer-Haerdi, et al.
Journal of Pathology Informatics|March 9, 2016
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancerNiels J Rupp, Peter J Schüffler, Qing Zhong, et al.
European Urology|December 13, 2005
Laparoscopic radical prostatectomy--the experience of the German Laparoscopic Working GroupJens Rassweiler, Jens Stolzenburg, Tullio Sulser, et al.
Neoplasia (New York, N.Y.)|July 19, 2012
Identification and functional characterization of pVHL-dependent cell surface proteins in renal cell carcinomaGunther Boysen, Damaris Bausch-Fluck, Claudio R Thoma, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2018
Clinical impact of <sup>68</sup>Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introductionJulian Müller, Daniela A Ferraro, Urs J Muehlematter, et al.
The Prostate|February 18, 2021
Benefit of a more extended pelvic lymph node dissection among patients undergoing radical prostatectomy for localized prostate cancer: A causal mediation analysisMarian S Wettstein, Luke A David, Clinsy Pazhepurackel, et al.
Urologic Oncology|August 2, 2015
Salvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial designWillemien van den Bos, Berrend G Muller, Daniel M de Bruin, et al.
Pageof 18